ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623639 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623639; 2) Community: the network communities that were significantly associated with the response to NSC 623639; 3) Molecule: the relationships between components within communities and NSC 623639; 4) MDR: the compounds that were significantly associated with the NSC 623639.

NSC Compound Enrichment Correlation
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0312262198176283 0.7830949
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0312262198176283 0.64613159
NSC 38643 Lenamycin 0.0312262198176283 0.57125977
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0312262198176283 0.8533832
NSC 621336 Null 0.0312262198176283 0.579421
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0352383000003052 0.65036389
NSC 626162 Discorhabdin C . TFA 0.0352383000003052 0.81306966
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.0352383000003052 -0.21865798
NSC 629595 Null 0.0352383000003052 0.61670177
NSC 638241 Null 0.0352383000003052 0.51431697
Total:136  Current:104    [First] [Prev] [Next] [Last]